Dr. Drew Moghanaki Joins LCFA’s Scientific Advisory Board

Welcoming Dr. Drew Moghanaki to LCFA’s Advisory Team

The Lung Cancer Foundation of America (LCFA) has announced the exciting appointment of Dr. Drew Moghanaki to its Scientific Advisory Board (SAB). As a distinguished Radiation Oncologist and Chief of Thoracic Oncology at UCLA Health, Dr. Moghanaki brings invaluable expertise to further LCFA's goals in lung cancer treatment and research. His work is particularly focused on the unique challenges faced by veterans, who often face elevated lung cancer risks due to service-related exposures.

Championing Veteran Lung Cancer Awareness

Dr. Moghanaki has been a strong advocate for lung cancer screening, particularly among veterans through LCFA's initiative, the 'Breath of Honor' campaign. This program seeks to elevate awareness and access to screening for individuals who have served in the military. His efforts have been instrumental in securing over $50 million aimed at enhancing early detection methods and clinical trials within the Veterans Affairs (VA) healthcare system, key initiatives like VA-PALS and the VALOR trial are noteworthy contributions.

The Role of the Scientific Advisory Board

LCFA’s Scientific Advisory Board comprises dedicated experts who volunteer their time to provide guidance and support in various ways. They oversee research investments and new program proposals while ensuring adherence to the foundation's mission to combat lung cancer.

Key Responsibilities of the SAB

• Provide scientific and strategic leadership to further LCFA’s mission.
• Evaluate and advise on new lung cancer research initiatives.
• Assist in research investment decisions and grant assessments.
• Support initiatives to attract top-tier researchers into lung cancer research.
• Identify programs that align with LCFA’s mission for greater impact.

Impact Through Research Funding

LCFA continues to play a significant role in funding innovative research, having supported 22 early career researchers with $4.4 million in grants. These investments have yielded profound results, enabling recipients to secure further funding from major entities such as the National Cancer Institute (NCI). This has culminated in a remarkable tenfold return on investment, achieving an impressive total of $43 million by the end of 2024. Such strategic funding is crucial in advancing lung cancer knowledge, treatment options, and improving patient outcomes.

About UCLA Health

UCLA Health is recognized as a leading healthcare institution, known for its comprehensive services and groundbreaking medical research. Comprising several medical facilities, including the renowned UCLA Medical Center, it is equipped with a diverse range of specialty clinics and a robust academic environment. The institution prides itself on its exceptional medical staff, with a significant number recognized among America's best doctors, ensuring that patients receive top-tier care.

LCFA’s Mission for Lung Cancer Awareness and Support

The Lung Cancer Foundation of America is dedicated to eradicating lung cancer through funding research and supporting education initiatives. With a robust commitment to enhancing patient outcomes, LCFA plays an essential role in advocating for increased research funding and awareness about lung cancer. Through collaborative efforts, the organization seeks to transform lung cancer outcomes and elevate the level of care available to patients.

Frequently Asked Questions

What is the role of Dr. Drew Moghanaki at LCFA?

Dr. Drew Moghanaki serves on LCFA’s Scientific Advisory Board, where he contributes his expertise in Radiation Oncology to advance lung cancer research and advocacy.

What initiatives has Dr. Moghanaki led for veterans?

Dr. Moghanaki has led the 'Breath of Honor' campaign, focusing on increasing lung cancer screening and awareness among veterans.

How does the SAB contribute to LCFA’s mission?

The SAB provides strategic oversight and guidance on research investments, helping to shape effective lung cancer research programs.

What funding has LCFA secured for research?

LCFA has funded more than $4.4 million in grants to early career researchers, significantly enhancing lung cancer research outcomes.

What is LCFA’s overall mission?

LCFA is committed to eradicating lung cancer through research funding, educational initiatives, and raising awareness about the disease and its impacts.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.